Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience
Bone Marrow Transplantation2012Vol. 48(4), pp. 491–501
Citations Over TimeTop 10% of 2012 papers
Rita Beier, André Schulz, Manfred Hönig, Matthias Eyrich, P-G Schlegel, Wolfgang Holter, Klaus Daniel Stachel, Karoline Ehlert, Johann Greil, W. Nürnberger, Wilhelm Wößmann, Peter Bader, Christian Urban, Ingo Müller, Meinolf Suttorp, Martin Sauer, B. Gruhn, Roland Meisel, Martin Zimmermann, K-W Sykora
Related Papers
- → Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies(2020)33 cited
- → Bone marrow transplantation for non‐malignant diseases using treosulfan‐based conditioning(2014)26 cited
- → Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)(2021)4 cited
- → Escalating Topotecan in Combination with Treosulfan has Acceptable Toxicity in Advanced Pediatric Sarcomas(2013)1 cited
- → Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders(2019)